Pharmaceutical Company Granted Fast Track Designation By FDA For Fibromyalgia Treatment

Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP), a fully-integrated biopharmaceutical company with marketed products and a pipeline of development candidates, recently announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to Tonmya™ (cyclobenzaprine HCl sublingual tablets) for the management of fibromyalgia. The Fast Track designation highlights both the critical nature of fibromyalgia and the potential of Tonmya to fill an unmet medical need. $Tonix Pharmaceuticals (TNXP.US)$